Log In
Print
BCIQ
Print
Print this Print this
 

HA-Irinotecan

Also known as: HyCAMP

  Manage Alerts
Collapse Summary General Information
Company Alchemia Ltd.
DescriptionIV formulation of irinotecan and hyaluronic acid developed using HyACT technology
Molecular Target Topoisomerase I (TOP1)
Mechanism of ActionTopoisomerase I inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today